UBS AM
NUVA

UBS AM’s NuVasive, Inc. NUVA Stock Holding History

UBS AM’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-53,054
Closed -$2.19M – 2724
2023
Q2 		$2.19M Hold
53,054
– – ﹤0.01% 1605
2023
Q1 		$2.19M Buy
53,054
+4,892
+10% +$209K ﹤0.01% 1605
2022
Q4 		$1.99M Sell
48,162
-1,168
-2% -$47.3K ﹤0.01% 1528
2022
Q3 		$2.16M Sell
49,330
-15,055
-23% -$730K ﹤0.01% 1560
2022
Q2 		$3.17M Sell
64,385
-492
-0.8% -$26.4K ﹤0.01% 1404
2022
Q1 		$3.68M Buy
64,877
+8,055
+14% +$428K ﹤0.01% 1486
2021
Q4 		$2.98M Sell
56,822
-1,132
-2% -$61.5K ﹤0.01% 1678
2021
Q3 		$3.47M Sell
57,954
-681
-1% -$42K ﹤0.01% 1541
2021
Q2 		$3.97M Buy
58,635
+1,326
+2% +$90.5K ﹤0.01% 1483
2021
Q1 		$3.76M Sell
57,309
-2,010
-3% -$121K ﹤0.01% 1473
2020
Q4 		$3.34M Buy
59,319
+3,901
+7% +$192K ﹤0.01% 1463
2020
Q3 		$2.69M Sell
55,418
-173
-0.3% -$9.32K ﹤0.01% 1420
2020
Q2 		$3.09M Buy
55,591
+492
+0.9% +$28.5K ﹤0.01% 1343
2020
Q1 		$2.79M Sell
55,099
-2,137
-4% -$143K ﹤0.01% 1279
2019
Q4 		$4.43M Buy
57,236
+2,393
+4% +$169K ﹤0.01% 1241
2019
Q3 		$3.48M Buy
54,843
+8,781
+19% +$549K ﹤0.01% 1357
2019
Q2 		$2.7M Buy
46,062
+4,464
+11% +$263K ﹤0.01% 1440
2019
Q1 		$2.36M Buy
41,598
+4,805
+13% +$255K ﹤0.01% 1438
2018
Q4 		$1.82M Buy
36,793
+1,705
+5% +$103K ﹤0.01% 1468
2018
Q3 		$2.49M Sell
35,088
-102
-0.3% -$6.49K ﹤0.01% 1415
2018
Q2 		$1.83M Sell
35,190
-1,323
-4% -$69.3K ﹤0.01% 1544
2018
Q1 		$1.91M Buy
36,513
+3,831
+12% +$194K ﹤0.01% 1489
2017
Q4 		$1.91M Buy
32,682
+2,399
+8% +$136K ﹤0.01% 1452
2017
Q3 		$1.68M Buy
30,283
+2,017
+7% +$133K ﹤0.01% 1471
2017
Q2 		$2.17M Sell
28,266
-250
-0.9% -$18.7K ﹤0.01% 1332
2017
Q1 		$2.13M Buy
28,516
+5,189
+22% +$377K ﹤0.01% 1325
2016
Q4 		$1.57M Sell
23,327
-13,914
-37% -$897K ﹤0.01% 1383
2016
Q3 		$2.48M Buy
37,241
+4,389
+13% +$280K ﹤0.01% 1297
2016
Q2 		$1.96M Buy
32,852
+6,586
+25% +$356K ﹤0.01% 1372
2016
Q1 		$1.28M Sell
26,266
-7,250
-22% -$329K ﹤0.01% 1542
2015
Q4 		$1.81M Buy
33,516
+1,305
+4% +$66.6K ﹤0.01% 1480
2015
Q3 		$1.55M Buy
32,211
+11,412
+55% +$590K ﹤0.01% 1540
2015
Q2 		$985K Buy
20,799
+2,600
+14% +$122K ﹤0.01% 1686
2015
Q1 		$837K Buy
18,199
+900
+5% +$41.8K ﹤0.01% 1709
2014
Q4 		$816K Buy
17,299
+1,000
+6% +$41.7K ﹤0.01% 1683
2014
Q3 		$568K Hold
16,299
– – ﹤0.01% 1803
2014
Q2 		$580K Buy
16,299
+1,500
+10% +$51.3K ﹤0.01% 1827
2014
Q1 		$568K Buy
14,799
+100
+0.7% +$3.67K ﹤0.01% 1821
2013
Q4 		$475K Sell
14,699
-900
-6% -$27K ﹤0.01% 1845
2013
Q3 		$382K Buy
15,599
+2,000
+15% +$49.2K ﹤0.01% 1926
2013
Q2 		$337K Buy
+13,599
New +$298K ﹤0.01% 1921

Other funds holding NUVA

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

UBS AM's NUVA Position: Q3 2023 in Review

UBS AM sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 53,054 shares — an estimated $2.19M sold.

UBS AM first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $4.43M in Q4 2019. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • UBS AM reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • UBS AM sold 53,054 NuVasive, Inc. shares in Q3 2023, an estimated $2.19M.
  • UBS AM first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
  • UBS AM's NuVasive, Inc. position peaked at $4.43M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on UBS AM's 13F filing for Q3 2023, filed 13 Nov 2023.